Predicting cisplatin tolerability in older adults with head and neck cancer – Insights for improved chemoradiation outcomes
We developed predictive models to support clinicians in identifying older adults with HNSCC capable of tolerating ≥ 200 mg/m<sup>2</sup> cumulative cisplatin during chemoradiation. Once validated, these models could improve personalized treatments and enhance shared decision-making in older adults with HNSCC.
Authors
- Marcelo Raul Bonomi (ORCID: https://orcid.org/0000-0002-9399-3608)
- Carmen Stromberger (ORCID: https://orcid.org/0000-0001-6165-1729)
- M. Weymann
- Sebastian Marschner (ORCID: https://orcid.org/0000-0002-8121-358X)
- Harald Binder (ORCID: https://orcid.org/0000-0002-5666-8662)
- Carmen Kut (ORCID: https://orcid.org/0000-0003-4957-7946)
- Daniel R. Dickstein (ORCID: https://orcid.org/0000-0003-4606-5574)
- Clemens Seidel (ORCID: https://orcid.org/0000-0001-8178-5089)
- Alev Altay-Langguth
- Erik Haehl (ORCID: https://orcid.org/0000-0002-2222-7324)
- Alexander Fabian (ORCID: https://orcid.org/0000-0003-2415-527X)
- Johannes Kraft (ORCID: https://orcid.org/0000-0002-5966-1271)
- Sachin R. Jhawar (ORCID: https://orcid.org/0000-0001-8604-4757)
- Peter Hambsch
- Harry Quon (ORCID: https://orcid.org/0000-0001-7605-4329)
- Arnulf Mayer (ORCID: https://orcid.org/0000-0002-3101-9180)
- Claus Belka (ORCID: https://orcid.org/0000-0002-1287-7825)
- Max Behrens (ORCID: https://orcid.org/0000-0002-4185-4702)
- Sören Schnellhardt (ORCID: https://orcid.org/0000-0003-0418-4401)
- Anca-Ligia Grosu (ORCID: https://orcid.org/0000-0003-2255-2255)
- Alexander Rühle (ORCID: https://orcid.org/0000-0003-2022-897X)
- Heinz Schmidberger (ORCID: https://orcid.org/0000-0003-0647-8884)
- Carolin Senger (ORCID: https://orcid.org/0000-0001-7700-4657)
- Goda Kalinauskaitė (ORCID: https://orcid.org/0000-0003-3798-1546)
- Sujith Baliga (ORCID: https://orcid.org/0000-0002-8032-2071)
- Panagiotis Balermpas (ORCID: https://orcid.org/0000-0001-5261-6446)
- Dukagjin M. Blakaj (ORCID: https://orcid.org/0000-0002-1718-9642)
- Marlen Haderlein (ORCID: https://orcid.org/0000-0002-7986-2169)
- Thomas Kuhnt
- Esmée L. Looman (ORCID: https://orcid.org/0000-0002-0026-0553)
- Victor Lewitzki (ORCID: https://orcid.org/0000-0001-9146-3083)
- Jens von der Grün (ORCID: https://orcid.org/0000-0002-9371-7814)
- Claudia Leucht
- Constantinos Zamboglou (ORCID: https://orcid.org/0000-0002-7849-7550)
- Jörg Andreas Müller (ORCID: https://orcid.org/0000-0003-0843-7373)
- Justus Domschikowski (ORCID: https://orcid.org/0000-0001-6174-1302)
- Nils H. Nicolay (ORCID: https://orcid.org/0000-0003-2550-1410)
- Eric Yu Hai Chen (ORCID: https://orcid.org/0000-0002-5247-3593)
- Konstantinos Ferentinos (ORCID: https://orcid.org/0000-0003-1391-6600)
- A.N. Elguindy
- Benjamin P. Bakst
- Johannes Olbrich
Institutions
- Goethe University Frankfurt (DE)
- Johns Hopkins University (US)
- University of Freiburg (DE)
- German Cancer Research Center (DE)
- Johannes Gutenberg University Mainz (DE)
- European University Cyprus (CY)
- University of Zurich (CH)
- Heidelberg University (DE)
- University Medical Center Freiburg (DE)
- University Hospital Heidelberg (DE)
- The Ohio State University Wexner Medical Center (US)
- University of Cyprus (CY)
- Humboldt-Universität zu Berlin (DE)
- Universitätsklinikum Erlangen (DE)
- University Hospital of Zurich (CH)
- German Cancer Society (DE)
- University Hospital Schleswig-Holstein (DE)
- University Hospitals Seidman Cancer Center (US)
- University Hospital Leipzig (DE)
- Universitätsklinikum Würzburg (DE)
- Comprehensive Cancer Center Erlangen (DE)
- University Hospital in Halle (DE)
- Ludwig-Maximilians-Universität München (DE)
- College of Mount Saint Vincent (US)
- Leipzig University (DE)
- University of Lübeck (DE)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1016/j.radonc.2024.110697
- Citations
- 5
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.90